Pages that link to "Q5544506"
Jump to navigation
Jump to search
The following pages link to Bo Ahrén (Q5544506):
Displaying 50 items.
- Per-Olov Ahrén (Q5544511) (← links)
- A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs (Q21245074) (← links)
- Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance? (Q21256397) (← links)
- A paleolithic diet is more satiating per calorie than a mediterranean-like diet in individuals with ischemic heart disease (Q24621806) (← links)
- Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats (Q24625957) (← links)
- Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study (Q24654138) (← links)
- Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes (Q26827955) (← links)
- DPP-4 inhibition and islet function (Q27028127) (← links)
- G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. (Q27865197) (← links)
- The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice (Q28257815) (← links)
- Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes (Q28260260) (← links)
- Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects (Q28293086) (← links)
- A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease (Q28307231) (← links)
- Neonatal capsaicin-treatment in mice: effects on pancreatic peptidergic nerves and 2-deoxy-D-glucose-induced insulin and glucagon secretion (Q28316273) (← links)
- Galanin-immunoreactive nerves in the mouse and rat pancreas (Q28324014) (← links)
- Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin (Q28565526) (← links)
- Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology (Q28863896) (← links)
- Role of VIP and PACAP in islet function (Q30832022) (← links)
- A 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats (Q30997105) (← links)
- Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications (Q31104386) (← links)
- The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes (Q31131756) (← links)
- Beta-cell-targeted expression of a dominant-negative mutant of hepatocyte nuclear factor-1alpha in mice: diabetes model with beta-cell dysfunction partially rescued by nonglucose secretagogues (Q31131767) (← links)
- Gut peptides and type 2 diabetes mellitus treatment (Q31157033) (← links)
- Direct cytoplasmic CA(2 ) responses to gastrin-releasing peptide in single beta cells (Q31855529) (← links)
- Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice (Q32062812) (← links)
- Overweight is associated with lower serum leptin in Peruvian Indian than in Caucasian women: A dissociation contributing to low blood pressure? (Q32076408) (← links)
- Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice (Q33196495) (← links)
- Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes (Q33209301) (← links)
- CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight (Q33216230) (← links)
- Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year (Q33220335) (← links)
- Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice (Q33223590) (← links)
- Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice (Q33224079) (← links)
- The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice (Q33236116) (← links)
- Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties (Q33237060) (← links)
- Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects (Q33275901) (← links)
- Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet (Q33283676) (← links)
- DPP-4 inhibitors (Q33308406) (← links)
- Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice (Q33317451) (← links)
- Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db mice (Q33509686) (← links)
- Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. (Q33518270) (← links)
- The canine sympathetic neuropeptide galanin: a neurotransmitter in pancreas, a neuromodulator in liver (Q33697322) (← links)
- Study on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet (Q33722778) (← links)
- GLP-1 released to the mesenteric lymph duct in mice: effects of glucose and fat. (Q33745485) (← links)
- Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy (Q33751433) (← links)
- GLP-1 for type 2 diabetes (Q33794098) (← links)
- Glucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice (Q33800196) (← links)
- Impact of glucose dosing regimens on modeling of glucose tolerance and β-cell function by intravenous glucose tolerance test in diet-induced obese mice (Q33902884) (← links)
- Islet amyloid and type 2 diabetes mellitus (Q33912902) (← links)
- Phospholipase A2 and its potential regulation of islet function (Q33918661) (← links)
- Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance (Q33968320) (← links)